Presentation

Moovcare® application detects anomalies in the follow-up of lung cancer patients and alerts the medical team if needed. It is the only medical application that was proven in clinical studies to increase survival in 7.6 months and 1st DTx reimbursed in France.

Contact

ayala.bliah@sivan-innovation.com

Address

6 rue Paul Baudry 75008, Paris, France

Website

https://www.sivan-innovation.com/

Targeted indications : Lung cancer